GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sysmex Corp (OTCPK:SSMXY) » Definitions » Cyclically Adjusted Revenue per Share

Sysmex (Sysmex) Cyclically Adjusted Revenue per Share : $3.46 (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Sysmex Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Sysmex's adjusted revenue per share for the three months ended in Mar. 2024 was $1.444. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $3.46 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Sysmex's average Cyclically Adjusted Revenue Growth Rate was 11.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Sysmex was 11.40% per year. The lowest was 8.40% per year. And the median was 9.45% per year.

As of today (2024-06-10), Sysmex's current stock price is $16.54. Sysmex's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $3.46. Sysmex's Cyclically Adjusted PS Ratio of today is 4.78.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Sysmex was 12.79. The lowest was 4.36. And the median was 7.24.


Sysmex Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Sysmex's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sysmex Cyclically Adjusted Revenue per Share Chart

Sysmex Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.27 3.50 3.46 3.63 3.46

Sysmex Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.63 3.42 3.38 3.67 3.46

Competitive Comparison of Sysmex's Cyclically Adjusted Revenue per Share

For the Medical Instruments & Supplies subindustry, Sysmex's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sysmex's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sysmex's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Sysmex's Cyclically Adjusted PS Ratio falls into.



Sysmex Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sysmex's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.444/107.2000*107.2000
=1.444

Current CPI (Mar. 2024) = 107.2000.

Sysmex Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.735 98.000 0.804
201409 0.782 98.500 0.851
201412 0.761 97.900 0.833
201503 0.870 97.900 0.953
201506 0.745 98.400 0.812
201509 0.853 98.500 0.928
201512 0.840 98.100 0.918
201603 0.947 97.900 1.037
201606 0.897 98.100 0.980
201609 0.936 98.000 1.024
201612 0.854 98.400 0.930
201703 0.978 98.100 1.069
201706 0.889 98.500 0.968
201709 1.000 98.800 1.085
201712 1.012 99.400 1.091
201803 1.186 99.200 1.282
201806 0.956 99.200 1.033
201809 0.999 99.900 1.072
201812 1.026 99.700 1.103
201903 1.222 99.700 1.314
201906 1.012 99.800 1.087
201909 1.104 100.100 1.182
201912 1.099 100.500 1.172
202003 1.242 100.300 1.327
202006 0.897 99.900 0.963
202009 1.081 99.900 1.160
202012 1.224 99.300 1.321
202103 1.364 99.900 1.464
202106 1.147 99.500 1.236
202109 1.291 100.100 1.383
202112 1.260 100.100 1.349
202203 1.408 101.100 1.493
202206 1.023 101.800 1.077
202209 1.200 103.100 1.248
202212 1.236 104.100 1.273
202303 1.331 104.400 1.367
202306 1.074 105.200 1.094
202309 1.264 106.200 1.276
202312 1.263 106.800 1.268
202403 1.444 107.200 1.444

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Sysmex  (OTCPK:SSMXY) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Sysmex's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=16.54/3.46
=4.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Sysmex was 12.79. The lowest was 4.36. And the median was 7.24.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Sysmex Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Sysmex's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Sysmex (Sysmex) Business Description

Industry
Traded in Other Exchanges
Address
1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, JPN, 6510073
Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.

Sysmex (Sysmex) Headlines

From GuruFocus

Matthews Japan Fund Comments on Sysmex

By Vera Yuan Vera Yuan 02-05-2015

Matthews Japan Fund Q4 2014 Commentary

By Vera Yuan Vera Yuan 02-05-2015

Vanguard Health Care Fund Gains 4 International Stocks in 2nd Quarter

By Sydnee Gatewood Sydnee Gatewood 08-04-2017

Matthews Japan Fund Comments on Sysmex

By Sydnee Gatewood Sydnee Gatewood 10-21-2020